{"title":"Assessment of risk perception of patients concerning adverse drug reactions","authors":"J. Joaquim, C. Matos, R. Mateos-Campos","doi":"10.2478/cipms-2023-0018","DOIUrl":null,"url":null,"abstract":"Abstract Introduction. The use of medicines involves trade-offs between their therapeutic benefits and inherent risks. Several studies show that numerous adverse drug reactions (ADRs) could be avoided by increasing patients’ awareness of medicine’s risks. Even though drug labels enclose relevant information about risks and benefits, this information often requires patient education and overall health literacy to improve medication adherence, thereby preventing ADR frequency. Aim. To describe patient awareness of ADR risks and the Portuguese Pharmacovigilance System. Methods. A questionnaire comprising 27 questions was conducted at a health centre in Coimbra, Portugal. This study included ninety-one patients. Risk perception was scored as positive (≥2.5 points) or negative (<2.5 points). Results were analysed by SPSS v 27.0. Results. This work highlights poor patient perceptions of risk with a rate of negative responses of 85,7%. Although some responders were aware of the possibility of reporting ADRs, only some participants were familiar with the Portuguese Pharmacovigilance System. Additionally, only five patients – out of the vast majority of those who had previously encountered ADRs – reported the event to INFARMED. Conclusion. Patient low literacy regarding ADRs and the national reporting systems need to be urgently improved. Patient-centred communication strategies for recognising regulatory requirements and standards of product safety are important measures to achieve effective awareness through routine reporting within the Pharmacovigilance systems.","PeriodicalId":11071,"journal":{"name":"Current Issues in Pharmacy and Medical Sciences","volume":"36 1","pages":"103 - 107"},"PeriodicalIF":0.4000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Issues in Pharmacy and Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2478/cipms-2023-0018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 1
Abstract
Abstract Introduction. The use of medicines involves trade-offs between their therapeutic benefits and inherent risks. Several studies show that numerous adverse drug reactions (ADRs) could be avoided by increasing patients’ awareness of medicine’s risks. Even though drug labels enclose relevant information about risks and benefits, this information often requires patient education and overall health literacy to improve medication adherence, thereby preventing ADR frequency. Aim. To describe patient awareness of ADR risks and the Portuguese Pharmacovigilance System. Methods. A questionnaire comprising 27 questions was conducted at a health centre in Coimbra, Portugal. This study included ninety-one patients. Risk perception was scored as positive (≥2.5 points) or negative (<2.5 points). Results were analysed by SPSS v 27.0. Results. This work highlights poor patient perceptions of risk with a rate of negative responses of 85,7%. Although some responders were aware of the possibility of reporting ADRs, only some participants were familiar with the Portuguese Pharmacovigilance System. Additionally, only five patients – out of the vast majority of those who had previously encountered ADRs – reported the event to INFARMED. Conclusion. Patient low literacy regarding ADRs and the national reporting systems need to be urgently improved. Patient-centred communication strategies for recognising regulatory requirements and standards of product safety are important measures to achieve effective awareness through routine reporting within the Pharmacovigilance systems.
摘要介绍。药物的使用涉及其治疗益处和固有风险之间的权衡。一些研究表明,通过提高患者对药物风险的认识,可以避免许多药物不良反应(adr)。尽管药品标签上附有有关风险和益处的相关信息,但这些信息通常需要对患者进行教育和全面的健康素养,以提高服药依从性,从而防止不良反应的发生。的目标。描述患者对不良反应风险的认识和葡萄牙药物警戒系统。方法。在葡萄牙科英布拉的一个保健中心进行了一份包含27个问题的调查表。这项研究包括91名患者。风险感知分为正面(≥2.5分)和负面(<2.5分)。结果用SPSS v 27.0进行分析。结果。这项工作突出了不良的风险患者的认知率为85,7%的负面反应。虽然一些应答者意识到报告不良反应的可能性,但只有一些参与者熟悉葡萄牙药物警戒系统。此外,只有5名患者(在绝大多数以前遇到过adr的患者中)向INFARMED报告了这一事件。结论。患者对不良反应的低识字率和国家报告系统亟待改善。以患者为中心的沟通策略,以识别法规要求和产品安全标准,是通过药物警戒系统内的常规报告实现有效认识的重要措施。